Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-13 of 13 for your search:
Cancer Type/Condition:
Thyroid cancer
Stage/Subtype:
stage III papillary thyroid cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Nexavar® Versus Placebo in Locally Advance RAI-Refractory Differentiated Thyroid Cancer
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
14295
, NCT00984282
2.
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
A4061027
, NCT00389441
3.
Phase II Study of Sorafenib Tosylate in Patients With Metastatic or Unresectable, Iodine Non-Avid, Resistant Thyroid Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
UPCC-03305
, UPCC#03305, UPCC-802861, NCT00601783
4.
Phase II Study of Pazopanib Hydrochloride in Patients With Advanced Thyroid Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC057H
, MC057H, 7627, NCT00625846
5.
Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WCI-2007-214
, NCT00668811
6.
Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
802861
, UPCC 03305, NCT00654238
7.
Phase II Study of Aflibercept in Patients With Poor Prognostic Recurrent and/or Metastatic Thyroid Cancer That is Refractory To Radioactive Iodine Therapy
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MSKCC-08066
, 08-066, 7508, NCT00729157
8.
Evaluating the Safety and Efficacy of Oral E7080 in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
E7080-G000-201
, NCT00784303
9.
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
090138
, 09-C-0138, NCT00923481
10.
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
09-049
, NCT00936858
11.
Study of Iodine I 131 Therapy in Patients With Thyroid Cancer
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 100
Sponsor:
NCI
Protocol IDs:
JHOC-J0628
, NCT00416949
12.
A Proof-of-Concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
GE-135-003
, NCT00565721
13.
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
COMIRB# 07-0727
, NCT00718770
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
